COSMOS PharmaceuticalCOSMOS Pharmaceutical Corporation3349東証プライム小売業FY ending May 2026, consolidated, J-GAAP

COSMOS Pharmaceutical FY ending May 2020 results

COSMOS Pharmaceutical brought in ¥684.4B in revenue.

Out of every ¥100 of sales, about ¥4 is left as operating profit.

Where the money goes

For every ¥100 COSMOS Pharmaceutical sells, how much goes where, and how much is kept.

FY ending May 2020

Margin funnel (derived from reported values)Gross margin 19.7% → Operating margin 4.3% → Net margin 3.1%

Show source documents (3)

EDINET (FSA Japan)
有価証券報告書－第42期(2023/06/01－2024/05/31)
ID S100UAMF2024-08-29Open
EDINET (FSA Japan)
有価証券報告書－第40期(令和3年6月1日－令和4年5月31日)
ID S100P3732022-08-30Open
EDINET (FSA Japan)
有価証券報告書－第39期(令和2年6月1日－令和3年5月31日)
ID S100MD0R2021-08-30Open

Extracted from XBRL: 43 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.